{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:31:43Z","timestamp":1778038303641,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00401-011-0926-8","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T04:26:09Z","timestamp":1323750369000},"page":"671-683","source":"Crossref","is-referenced-by-count":91,"title":["Aggregation of \u03b1Synuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons"],"prefix":"10.1007","volume":"123","author":[{"given":"Grit","family":"Taschenberger","sequence":"first","affiliation":[]},{"given":"Manuel","family":"Garrido","sequence":"additional","affiliation":[]},{"given":"Yuliya","family":"Tereshchenko","sequence":"additional","affiliation":[]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[]},{"given":"Markus","family":"Zweckstetter","sequence":"additional","affiliation":[]},{"given":"Sebastian","family":"K\u00fcgler","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,12,14]]},"reference":[{"key":"926_CR1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev.cellbio.042308.113313","volume":"26","author":"PK Auluck","year":"2010","unstructured":"Auluck PK, Caraveo G, Lindquist S (2010) Alpha-Synuclein: membrane interactions and toxicity in Parkinson\u2019s disease. Annu Rev Cell Dev Biol 26:211\u2013233","journal-title":"Annu Rev Cell Dev Biol"},{"key":"926_CR2","first-page":"872","volume":"18","author":"S Azeredo da Silveira","year":"2009","unstructured":"Azeredo da Silveira S, Schneider BL, Cifuentes-Diaz C et al (2009) Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson\u2019s disease. Hum Mol Genet 18:872\u2013887","journal-title":"Hum Mol Genet"},{"key":"926_CR3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ (2011) Alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477:107\u2013110","journal-title":"Nature"},{"key":"926_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-008-0409-8","volume":"116","author":"TG Beach","year":"2008","unstructured":"Beach TG, White CL, Hamilton RL et al (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116:277\u2013288","journal-title":"Acta Neuropathol"},{"key":"926_CR5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","volume":"1804","author":"M Biancalana","year":"2010","unstructured":"Biancalana M, Koide S (2010) Molecular mechanism of thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta 1804:1405\u20131412","journal-title":"Biochim Biophys Acta"},{"key":"926_CR6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B Caughey","year":"2003","unstructured":"Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267\u2013298","journal-title":"Annu Rev Neurosci"},{"key":"926_CR7","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","volume":"29","author":"CY Chung","year":"2009","unstructured":"Chung CY, Koprich JB, Siddiqi H, Isacson O (2009) Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. J Neurosci 29:3365\u20133373","journal-title":"J Neurosci"},{"key":"926_CR8","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","volume":"39","author":"KA Conway","year":"2000","unstructured":"Conway KA, Harper JD, Lansbury PT Jr (2000) Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson\u2019s disease are typical amyloid. Biochemistry 39:2552\u20132563","journal-title":"Biochemistry"},{"key":"926_CR9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, Lansbury PT Jr (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci USA 97:571\u2013576","journal-title":"Proc Natl Acad Sci USA"},{"key":"926_CR10","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ et al (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106:13010\u201313015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"926_CR11","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/mds.23948","volume":"26","author":"MJ Devine","year":"2011","unstructured":"Devine MJ, Gwinn K, Singleton A, Hardy J (2011) Parkinson\u2019s disease and alpha-synuclein expression. Mov Disord 26(12):2160\u20132168","journal-title":"Mov Disord"},{"key":"926_CR12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/syn.20456","volume":"61","author":"PO Fernagut","year":"2007","unstructured":"Fernagut PO, Hutson CB, Fleming SM et al (2007) Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression. Synapse 61:991\u20131001","journal-title":"Synapse"},{"key":"926_CR13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/ar050073t","volume":"39","author":"AL Fink","year":"2006","unstructured":"Fink AL (2006) The aggregation and fibrillation of alpha-synuclein. Acc Chem Res 39:628\u2013634","journal-title":"Acc Chem Res"},{"key":"926_CR14","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson BI, Murray IV, Trojanowski JQ, Lee VM (2001) A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem 276:2380\u20132386","journal-title":"J Biol Chem"},{"key":"926_CR15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 51:745\u2013752","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"926_CR16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2010.10.014","volume":"68","author":"J Hardy","year":"2010","unstructured":"Hardy J (2010) Genetic analysis of pathways to Parkinson disease. Neuron 68:201\u2013206","journal-title":"Neuron"},{"key":"926_CR17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.gde.2009.03.008","volume":"19","author":"J Hardy","year":"2009","unstructured":"Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C (2009) The genetics of Parkinson\u2019s syndromes: a critical review. Curr Opin Genet Dev 19:254\u2013265","journal-title":"Curr Opin Genet Dev"},{"key":"926_CR18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afp223","volume":"39","author":"JV Hindle","year":"2010","unstructured":"Hindle JV (2010) Ageing, neurodegeneration and Parkinson\u2019s disease. Age Ageing 39:156\u2013161","journal-title":"Age Ageing"},{"key":"926_CR19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai A, Masliah E, Yoshimoto M et al (1995) The precursor protein of non-A beta component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14:467\u2013475","journal-title":"Neuron"},{"issue":"Suppl 6","key":"926_CR20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.10557","volume":"18","author":"KA Jellinger","year":"2003","unstructured":"Jellinger KA (2003) Neuropathological spectrum of synucleinopathies. Mov Disord 18(Suppl 6):2\u201312","journal-title":"Mov Disord"},{"key":"926_CR21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1326-2-6","volume":"2","author":"V Kallhoff","year":"2007","unstructured":"Kallhoff V, Peethumnongsin E, Zheng H (2007) Lack of alpha-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer\u2019s disease. Mol Neurodegener 2:6","journal-title":"Mol Neurodegener"},{"key":"926_CR22","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/emboj.2009.257","volume":"28","author":"DP Karpinar","year":"2009","unstructured":"Karpinar DP, Balija MB, K\u00fcgler S et al (2009) Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson\u2019s disease models. EMBO J 28:3256\u20133268","journal-title":"EMBO J"},{"key":"926_CR23","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","volume":"22","author":"D Kirik","year":"2002","unstructured":"Kirik D, Rosenblad C, Burger C et al (2002) Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci 22:2780\u20132791","journal-title":"J Neurosci"},{"key":"926_CR24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/10430340252837206","volume":"13","author":"RL Klein","year":"2002","unstructured":"Klein RL, King MA, Hamby ME, Meyer EM (2002) Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. Hum Gene Ther 13:605\u2013612","journal-title":"Hum Gene Ther"},{"key":"926_CR25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1750-3639.2003.tb00035.x","volume":"13","author":"E Lauwers","year":"2003","unstructured":"Lauwers E, Debyser Z, Van Dorpe J, De Strooper B, Nuttin B, Baekelandt V (2003) Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein. Brain Pathol 13:364\u2013372","journal-title":"Brain Pathol"},{"key":"926_CR26","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"HJ Lee","year":"2005","unstructured":"Lee HJ, Patel S, Lee SJ (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25:6016\u20136024","journal-title":"J Neurosci"},{"key":"926_CR27","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s11064-009-9986-8","volume":"34","author":"SL Leong","year":"2009","unstructured":"Leong SL, Cappai R, Barnham KJ, Pham CL (2009) Modulation of alpha-synuclein aggregation by dopamine: a review. Neurochem Res 34:1838\u20131846","journal-title":"Neurochem Res"},{"key":"926_CR28","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1021\/bi010616g","volume":"40","author":"J Li","year":"2001","unstructured":"Li J, Uversky VN, Fink AL (2001) Effect of familial Parkinson\u2019s disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry 40:11604\u201311613","journal-title":"Biochemistry"},{"key":"926_CR29","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","volume":"99","author":"C Lo Bianco","year":"2002","unstructured":"Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P (2002) Alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 99:10813\u201310818","journal-title":"Proc Natl Acad Sci USA"},{"key":"926_CR30","doi-asserted-by":"crossref","first-page":"19213","DOI":"10.1074\/jbc.M110551200","volume":"277","author":"H Miake","year":"2002","unstructured":"Miake H, Mizusawa H, Iwatsubo T, Hasegawa M (2002) Biochemical characterization of the core structure of alpha-synuclein filaments. J Biol Chem 277:19213\u201319219","journal-title":"J Biol Chem"},{"key":"926_CR31","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1523\/JNEUROSCI.5924-09.2010","volume":"30","author":"R Morales","year":"2010","unstructured":"Morales R, Estrada LD, Diaz-Espinoza R et al (2010) Molecular cross talk between misfolded proteins in animal models of Alzheimer\u2019s and prion diseases. J Neurosci 30:4528\u20134535","journal-title":"J Neurosci"},{"key":"926_CR32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/exnr.2002.7929","volume":"176","author":"F Mori","year":"2002","unstructured":"Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K (2002) Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp Neurol 176:98\u2013104","journal-title":"Exp Neurol"},{"key":"926_CR33","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","volume":"110","author":"M Neumann","year":"2002","unstructured":"Neumann M, Kahle PJ, Giasson BI et al (2002) Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Invest 110:1429\u20131439","journal-title":"J Clin Invest"},{"key":"926_CR34","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum RL, Ellis CE (2003) Alzheimer\u2019s disease and Parkinson\u2019s disease. N Engl J Med 348:1356\u20131364","journal-title":"N Engl J Med"},{"key":"926_CR35","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.1090439","volume":"302","author":"TF Outeiro","year":"2003","unstructured":"Outeiro TF, Lindquist S (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302:1772\u20131775","journal-title":"Science"},{"key":"926_CR36","unstructured":"R DCT (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. http:\/\/www.R-project.org"},{"key":"926_CR37","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/sj.gt.3302822","volume":"13","author":"Z Shevtsova","year":"2006","unstructured":"Shevtsova Z, Malik I, Garrido M, Sch\u00f6ll U, B\u00e4hr M, K\u00fcgler S (2006) Potentiation of in vivo neuroprotection by BclX(L) and GDNF co-expression depends on post-lesion time in deafferentiated CNS neurons. Gene Ther 13:1569\u20131578","journal-title":"Gene Ther"},{"key":"926_CR38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1113\/expphysiol.2004.028159","volume":"90","author":"Z Shevtsova","year":"2005","unstructured":"Shevtsova Z, Malik JM, Michel U, B\u00e4hr M, K\u00fcgler S (2005) Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Exp Physiol 90:53\u201359","journal-title":"Exp Physiol"},{"key":"926_CR39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/002215540205000403","volume":"50","author":"A Sun","year":"2002","unstructured":"Sun A, Nguyen XV, Bing G (2002) Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J Histochem Cytochem 50:463\u2013472","journal-title":"J Histochem Cytochem"},{"key":"926_CR40","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1523\/JNEUROSCI.4977-09.2010","volume":"30","author":"E Tsika","year":"2010","unstructured":"Tsika E, Moysidou M, Guo J et al (2010) Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration. J Neurosci 30:3409\u20133418","journal-title":"J Neurosci"},{"key":"926_CR41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/138920309789351921","volume":"10","author":"VN Uversky","year":"2009","unstructured":"Uversky VN, Eliezer D (2009) Biophysics of Parkinson\u2019s disease: structure and aggregation of alpha-synuclein. Curr Protein Pept Sci 10:483\u2013499","journal-title":"Curr Protein Pept Sci"},{"key":"926_CR42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/0929866043407174","volume":"11","author":"DM Walsh","year":"2004","unstructured":"Walsh DM, Selkoe DJ (2004) Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 11:213\u2013228","journal-title":"Protein Pept Lett"},{"key":"926_CR43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","volume":"231","author":"MJ West","year":"1991","unstructured":"West MJ, Slomianka L, Gundersen HJ (1991) Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482\u2013497","journal-title":"Anat Rec"},{"issue":"10","key":"926_CR44","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK et al (2011) In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci USA 108(10):4194\u20134199","journal-title":"Proc Natl Acad Sci USA"},{"key":"926_CR45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2004.05.118","volume":"367","author":"S Yu","year":"2004","unstructured":"Yu S, Zuo X, Li Y et al (2004) Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells. Neurosci Lett 367:34\u201339","journal-title":"Neurosci Lett"},{"key":"926_CR46","doi-asserted-by":"crossref","first-page":"20288","DOI":"10.1074\/jbc.M710560200","volume":"283","author":"NY Zhang","year":"2008","unstructured":"Zhang NY, Tang Z, Liu CW (2008) Alpha-Synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation: understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis. J Biol Chem 283:20288\u201320298","journal-title":"J Biol Chem"},{"key":"926_CR47","doi-asserted-by":"crossref","first-page":"16873","DOI":"10.1074\/jbc.M210136200","volume":"278","author":"M Zhu","year":"2003","unstructured":"Zhu M, Fink AL (2003) Lipid binding inhibits alpha-synuclein fibril formation. J Biol Chem 278:16873\u201316877","journal-title":"J Biol Chem"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00401-011-0926-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T17:07:19Z","timestamp":1561050439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-011-0926-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,14]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1007\/s00401-011-0926-8","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,14]]}}}